TWI330085B - - Google Patents

Download PDF

Info

Publication number
TWI330085B
TWI330085B TW093108535A TW93108535A TWI330085B TW I330085 B TWI330085 B TW I330085B TW 093108535 A TW093108535 A TW 093108535A TW 93108535 A TW93108535 A TW 93108535A TW I330085 B TWI330085 B TW I330085B
Authority
TW
Taiwan
Prior art keywords
lipid
mass
cyclic tetrasaccharide
feed
group
Prior art date
Application number
TW093108535A
Other languages
English (en)
Chinese (zh)
Other versions
TW200501964A (en
Inventor
Kazuyuki Oku
Michio Kubota
Shigeharu Fukuda
Toshio Miyake
Original Assignee
Hayashibara Biochem Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Biochem Lab filed Critical Hayashibara Biochem Lab
Publication of TW200501964A publication Critical patent/TW200501964A/zh
Application granted granted Critical
Publication of TWI330085B publication Critical patent/TWI330085B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW093108535A 2003-04-03 2004-03-29 Lipid-regulating agent and its usage TW200501964A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003100408 2003-04-03

Publications (2)

Publication Number Publication Date
TW200501964A TW200501964A (en) 2005-01-16
TWI330085B true TWI330085B (de) 2010-09-11

Family

ID=33156723

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093108535A TW200501964A (en) 2003-04-03 2004-03-29 Lipid-regulating agent and its usage

Country Status (7)

Country Link
US (2) US20060276432A1 (de)
EP (1) EP1616873B1 (de)
JP (1) JP4893981B2 (de)
CN (1) CN100540559C (de)
DE (1) DE602004015966D1 (de)
TW (1) TW200501964A (de)
WO (1) WO2004089964A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4702745B2 (ja) * 2003-07-18 2011-06-15 株式会社林原生物化学研究所 ミネラル吸収促進剤及びその用途
GB2445891B (en) * 2005-09-22 2010-11-10 Hayashibara Biochem Lab Immunomodulating agent in gut
JP2007267618A (ja) * 2006-03-30 2007-10-18 Mukogawa Gakuin ケーキ
JP2010053122A (ja) * 2008-07-31 2010-03-11 Hayashibara Biochem Lab Inc 脂質合成阻害剤
WO2010088222A2 (en) * 2009-01-27 2010-08-05 World Force Technologies, Llc A high molecular weight polysaccharide that binds and inhibits virus
JP2010215544A (ja) * 2009-03-13 2010-09-30 Hiroshima Univ 血管新生抑制剤、これを含有する医薬、血管新生抑制剤を産生させる整腸剤、並びに、血管新生抑制剤の投与方法
JP2014185088A (ja) * 2013-03-22 2014-10-02 Sunstar Inc 経口組成物、脂肪細胞分化抑制剤および飲食品
EP3391881A4 (de) * 2015-11-19 2020-03-11 Sinew Pharma Inc. Pharmazeutische zusammensetzung zur vorbeugung oder behandlung von fettleber
JP7136765B2 (ja) 2017-03-24 2022-09-13 株式会社林原 オートファジー誘導剤とその用途
FR3087339A1 (fr) * 2018-10-22 2020-04-24 Nexira Composition pour traiter le surpoids et/ou l'obesite
WO2021066159A1 (ja) 2019-10-04 2021-04-08 株式会社林原 環状四糖を含有する糖組成物とその用途並びに製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6094912A (ja) * 1983-10-28 1985-05-28 Masashige Suzuki 体内中性脂肪低減剤
JPH07115934A (ja) * 1993-10-22 1995-05-09 Hairu:Kk 痩身用食品
JPH08283154A (ja) * 1995-04-12 1996-10-29 Nippon Shinyaku Co Ltd 脂質代謝改善剤
US5786196A (en) * 1995-06-12 1998-07-28 The United States Of America As Represented By The Secretary Of Agriculture Bacteria and enzymes for production of alternan fragments
JP4919198B2 (ja) * 2000-05-22 2012-04-18 株式会社林原生物化学研究所 α−イソマルトシル転移酵素とその製造方法並びに用途
TWI312369B (en) 2000-08-01 2009-07-21 Hayashibara Biochem Lab A-isomaltosylglucosaccharide synthase,process for producing the same and use thereof
US7223570B2 (en) 2001-03-09 2007-05-29 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Branched cyclic tetrasaccharide, process for producing the same, and use
JP2003160595A (ja) * 2001-11-20 2003-06-03 Hayashibara Biochem Lab Inc 糖誘導体

Also Published As

Publication number Publication date
CN1768071A (zh) 2006-05-03
US20080214499A1 (en) 2008-09-04
WO2004089964A1 (ja) 2004-10-21
CN100540559C (zh) 2009-09-16
DE602004015966D1 (de) 2008-10-02
JP4893981B2 (ja) 2012-03-07
EP1616873B1 (de) 2008-08-20
US20060276432A1 (en) 2006-12-07
EP1616873A1 (de) 2006-01-18
WO2004089964A8 (ja) 2004-12-29
EP1616873A4 (de) 2007-01-10
TW200501964A (en) 2005-01-16
US8940715B2 (en) 2015-01-27
JPWO2004089964A1 (ja) 2006-07-06

Similar Documents

Publication Publication Date Title
US8940715B2 (en) Lipid-regulating agent and use thereof
JP5535456B2 (ja) 食物繊維と希少糖を含む生体機能改善組成物。
CA2473209C (en) Stimulation of the immune system with polydextrose
JP4702745B2 (ja) ミネラル吸収促進剤及びその用途
US20100204346A1 (en) Novel sweetener having sucrose-like taste, method for producing the same, and use of the same
JP6013712B2 (ja) Ｄ−プシコースを有効成分とする生体代謝パラメーター改善剤
JP5876205B2 (ja) Ｄ−ソルボースからなる甘味料におけるｄ−ソルボースの甘味の不足や、甘味の持続を改良する方法
WO2006101118A1 (ja) D-プシコースの血糖値日内異常上昇抑制の用途
WO2014133060A1 (ja) 抗生活習慣病用剤及びそれを含んでなる経口組成物
JP2010120945A (ja) 栄養性の改良されたイヌリン製品
KR20150145262A (ko) 에너지 소비의 촉진 및/또는 에너지 소비 기능 저하의 치료 및/또는 예방제, 또는 방법
US8722614B2 (en) Adiponectin production enhancer
JP5749880B2 (ja) Ｄ−タガトースを有効成分とする体脂肪蓄積改善剤およびメタボリックシンドローム改善剤
WO2005027892A1 (ja) インスリン初期分泌促進剤
TW200410702A (en) Agent for inhibiting rise in blood glucose level, agent for inhibiting body fat accumulation and edible material
JP2009161522A (ja) 腎障害抑制剤
CN101410101A (zh) 抗脂肪沉积用组合物
JP2011012005A (ja) 高脂血症改善剤
JP4746281B2 (ja) 生体内脂質調節剤
JPH0995448A (ja) 血中ビオチン濃度の増加方法およびビオチン含有飲食品
JP5943516B2 (ja) Ｄ−ソルボースを有効成分とする生体機能改善用甘味料
WO2018074415A1 (ja) たんぱく質効率向上用の組成物
CN118805891A (zh) 一种抑制脂肪吸收、控制体重的组合物及其制备方法
KR0144566B1 (ko) 비피드균 증식 촉진제
JPH10313822A (ja) 腸内細菌叢改善剤及びそれを含有する組成物

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees